Evidence map›Paper›PMID 20028533›Full record

ArticleBMC infectious diseases2009

Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay.

Iraklis Tsangaris, Diamantis Plachouras, Dimitra Kavatha, George Michael Gourgoulis, Argirios Tsantes, Petros Kopterides, George Tsaknis, Ioanna Dimopoulou, Stylianos Orfanos, Evangelos Giamarellos-Bourboulis and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in BMC infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07211620 (KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic Use), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07211620 narecruitingnot on this mapstarted 2025, after this paper: background citation

KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic Use (KIPRUN) - Protocol for a Multi-center, Randomized, Superiority Trial to Compare the Efficacy and Safety of Procalcitonin Kinetics-guided and Absolute Procalcitonin Value-guided Antibiotic Initiation in Reducing Unnecessary Antibiotic Therapy in Critically Ill Patients

TypeinterventionalSponsorSemmelweis UniversityRan2025 to 2027Enrolled250ConditionsInfection, SepsisArmsKinetics, Absolute
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Top stories of 2009.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Iraklis TsangarisThe 2nd Critical Care Department, Attikon University General Hospital, Medical School, University of Athens, 1 Rimini Str,, 12462, Athens, Greece. itsagkaris@med.uoa.gr
Diamantis Plachouras
Dimitra Kavatha
George Michael Gourgoulis
Argirios Tsantes
Petros Kopterides
George Tsaknis
Ioanna Dimopoulou
Stylianos Orfanos
Evangelos Giamarellos-Bourboulis
Helen Giamarellou
Apostolos Armaganidis

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProcalcitonin (PCT) has been proposed as a diagnostic and prognostic sepsis marker, but has never been validated in febrile patients with prolonged ICU stay.

methodsPatients were included in the study provided they were hospitalised in the ICU for > 10 days, were free of infection and presented a new episode of SIRS, with fever >38 degrees C being obligatory. Fifty patients fulfilled the above criteria. PCT was measured daily during the ICU stay. The primary outcome was proven infection.

resultsTwenty-seven out of 50 patients were diagnosed with infection. Median PCT on the day of fever was 1.18 and 0.17 ng/ml for patients with and without proven infections (p < 0.001). The area under the curve for PCT was 0.85 (95% CI; 0.71-0.93), for CRP 0.65 (0.46-0.78) and for WBC 0.68 (0.49-0.81). A PCT level of 1 ng/mL yielded a negative predictive value of 72% for the presence of infection, while a PCT of 1.16 had a specificity of 100%. A two-fold increase of PCT between fever onset and the previous day was associated with proven infection (p 0.001) (OR = 8.55; 2.4-31.1), whereas a four-fold increase of PCT of any of the 6 preceding days was associated with a positive predictive value exceeding 69.65%. A PCT value less than 0.5 ng/ml on the third day after the advent of fever was associated with favorable survival (p 0.01).

conclusionThe reported data support that serial serum PCT may be a valuable diagnostic and prognostic marker in febrile chronic critically ill patients.

Indexed as

AdultAgedAged, 80 and overArea Under CurveBacterial InfectionsBiomarkersCalcitoninCalcitonin Gene-Related PeptideCritical IllnessFemaleFeverHumansIntensive Care UnitsLength of StayMaleMiddle AgedBiomarkersCALCA protein, humanCalcitoninCalcitonin Gene-Related PeptideProtein Precursors

Identifiers

PMID20028533
PMCPMC2803794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.